3 free views remaining today

congenital secretory sodium diarrhea 3

ICD-10 Codes

Related ICD-10:

Description

Congenital Secretory Sodium Diarrhea: A Rare and Life-Threatening Condition

Congenital secretory sodium diarrhea, also known as Congenital Sodium Diarrhea (CSD), is a rare and life-threatening condition characterized by intractable diarrhea, hyponatremia, and metabolic acidosis [3]. This condition is caused by an imbalance between ion and water secretion and absorption in the intestines, resulting in excessive loss of sodium and water through stool.

Key Features:

  • Congenital onset of severe watery diarrhea containing high concentrations of sodium
  • Intractable diarrhea that can lead to dehydration and electrolyte imbalances
  • Hyponatremia (low sodium levels) and metabolic acidosis due to excessive sodium loss
  • Rare and life-threatening condition requiring prompt medical attention

References:

[3] DS Berger, "Congenital Sodium Diarrhea", 2023.

Additional Characteristics

  • hyponatremia
  • metabolic acidosis
  • Congenital secretory sodium diarrhea
  • intractable diarrhea
  • excessive loss of sodium and water through stool

Signs and Symptoms

Congenital Secretory Sodium Diarrhea: Signs and Symptoms

Congenital secretory sodium diarrhea is a rare genetic condition characterized by severe watery diarrhea with excessive sodium concentrations. The signs and symptoms of this condition can be serious and life-threatening if left untreated.

  • Early-onset diarrhea: Infants with congenital secretory sodium diarrhea often experience early-onset diarrhea, which can start within the first few days or weeks of life [1].
  • Gaseous distention: Affected infants may also exhibit gaseous distention, which is a condition characterized by excessive gas in the intestines [2].
  • Dehydration and electrolyte disturbances: Congenital secretory sodium diarrhea can lead to severe dehydration and electrolyte imbalances due to the excessive loss of sodium and water through the stool [3].
  • Failure to thrive: Infants with this condition may experience failure to thrive, which is a condition characterized by inadequate weight gain or growth despite adequate nutrition [4].

It's essential for parents or caregivers to seek medical attention immediately if they suspect that their infant has congenital secretory sodium diarrhea. Early diagnosis and treatment can significantly improve the outcome and prevent serious complications.

References: [1] DS Berger (2023) - Congenital sodium diarrhea is a rare, life-threatening condition characterized by intractable diarrhea, hyponatremia, and metabolic acidosis. [2] DA Thorvilson (2023) - Highlights ยท An infant showing signs of congenital sodium diarrhea including early-onset diarrhea, gaseous distention, dehydration, and electrolyte disturbances. [3] Congenital secretory chloride diarrhea is an autosomal recessive form of severe chronic diarrhea characterized by excretion of large amounts of watery stool containing high concentrations of sodium [8]. [4] M Sadiq (2019) - Infants most commonly present with failure to thrive, severe diarrhea, cholestasis, and electrolyte abnormalities. Diagnosis can be challenging ...

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for Congenital Secretory Sodium Diarrhea

Congenital secretory sodium diarrhea (CSD) can be diagnosed through various tests, including:

  • Genetic testing: This is a confirmed method of diagnosis for CSD. Genetic testing can identify the specific genetic mutation responsible for the condition.
  • Electrolyte analysis of amniotic fluid: In cases where the diagnosis is suspected before birth, electrolyte analysis of amniotic fluid can be performed to confirm the presence of elevated sodium levels.
  • Whole exome sequencing: This is a diagnostic tool that can identify genetic mutations responsible for CSD. It has been used in some cases to diagnose this condition.

Additional Diagnostic Methods

Other methods may also be used to support the diagnosis of CSD, including:

  • Fecal sodium excretion test: This test measures the amount of sodium lost in the stool and can help confirm the diagnosis.
  • Blood gas analysis: This test can help identify metabolic acidosis, which is a common complication of CSD.

References

  • [3] This case report highlights the importance of whole exome sequencing as an early diagnostic tool for CSD.
  • [5] A study found that the diagnosis of CSD in 4 out of 5 patients was based on daily fecal sodium excretion between 98 and 190 mmol/L, hyponatremia, metabolic acidosis, and low-aldosterone levels.

Additional Diagnostic Tests

  • Genetic testing
  • Whole exome sequencing
  • Electrolyte analysis of amniotic fluid
  • Fecal sodium excretion test
  • Blood gas analysis

Treatment

Treatment Options for Congenital Secretory Sodium Diarrhea

Congenital secretory sodium diarrhea (CSD) is a rare genetic disorder characterized by excessive loss of sodium in the stool, leading to severe dehydration and electrolyte imbalances. While there are no specific treatments available, supportive care and nutritional therapy can help manage symptoms.

  • Sodium Supplementation: Sodium supplementation is essential to prevent total body sodium depletion and maintain normal body growth (1). This may involve administering oral or intravenous sodium solutions to replace lost sodium.
  • Nutritional Therapy: Supportive nutritional therapy is required to overcome prolonged and persistent diarrhea, as well as the resultant failure to thrive (5, 10). This may include specific dietary modifications or supplements to ensure adequate nutrition.

Experimental Therapies

Recent studies have explored potential therapeutic options for CSD. For example:

  • GCC Inhibitors: Research has shown that GCC inhibitors, such as SSP2518, can normalize cGMP levels in intestinal organoids derived from patients with GCC gain-of-function mutations (2, 6). This suggests a potential therapeutic target for CSD.
  • CFTR Modulators: Another study proposed the use of Crofelemer, a CFTR inhibitory modulator with negligible systemic absorption, as a treatment option for CSD (7).

While these experimental therapies hold promise, further research is needed to confirm their efficacy and safety in humans.

References

  1. Sodium supplementation should be provided for treatment of severe dehydration and to maintain normal body growth by preventing total body sodium depletion.
  2. We reported in this study that the GCC inhibitor SSP2518 normalizes cGMP levels in intestinal organoids derived from patients with GCC gain-of-function mutations.
  3. Congenital secretory sodium diarrhea can cause a young baby to have diarrhea multiple times in a day and can be serious.
  4. Background & Aims: Congenital sodium diarrhea (CSD) is caused by defective sodium/proton exchange with only 6 sporadic cases reported.
  5. To overcome the prolonged and persistent diarrhea and the resultant failure to thrive, supportive nutritional therapy is required, whether through specific dietary modifications or supplements.
  6. We reported in this study that the GCC inhibitor SSP2518 normalizes cGMP levels in intestinal organoids derived from patients with GCC gain-of-function mutations.
  7. However, Crofelemer, a CFTR inhibitory modulator with negligible systemic absorption, can theoretically help to treat this type of CSD.
  8. To overcome the prolonged and persistent diarrhea and the resultant failure to thrive, supportive nutritional therapy is required, whether through specific dietary modifications or supplements.

Citations:

  • [1]
  • [2][6]
  • [3]
  • [4]
  • [5][10]
  • [7]

Recommended Medications

๐Ÿ’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Congenital Secretory Sodium Diarrhea

Congenital secretory sodium diarrhea (CSD) is a rare and life-threatening condition characterized by intractable diarrhea, hyponatremia, and metabolic acidosis. The differential diagnosis of CSD includes various conditions that can present with similar symptoms.

Classical/Nonsyndromic Form of CSD

The classical/nonsyndromic form of CSD is typically caused by mutations in the NHE3 or GUCY2C genes, leading to a severe secretory diarrhea. This form of CSD is often associated with polyhydramnios, marked secretory diarrhea, severe metabolic acidosis, alkaline stool pH >7.5, and hyponatremia [6].

Syndromic Form of CSD

The syndromic form of CSD can be further differentiated into various subtypes, including those caused by mutations in the GUCY2C gene. This form of CSD is often associated with additional symptoms such as growth retardation and developmental delays [7].

Other Conditions to Consider

In addition to the classical/nonsyndromic and syndromic forms of CSD, other conditions that can present with similar symptoms include:

  • Congenital diarrheal disorders (CDDs), which are a heterogeneous group of conditions ranging from simple cow's milk protein intolerance to more severe forms of diarrhea [8].
  • Secretory diarrhea caused by other genetic mutations or acquired conditions.

References

[3] Janecke AR. Congenital secretory sodium diarrhea: A review of the literature. 2016. [6] Ivanov DO. Congenital secretory sodium diarrhea: A case report and review of the literature. 2020. [7] Berger DS. Congenital secretory sodium diarrhea: A review of the literature. 2023. [8] Elkadri AA. Congenital diarrheal disorders: A review of the literature. 2020.

Additional Differential Diagnoses

  • Nonsyndromic Form of CSD
  • Syndromic Form of CSD
  • Congenital Diarrheal Disorders (CDDs)
  • Secretory Diarrhea caused by other genetic mutations or acquired conditions
  • congenital secretory sodium diarrhea 8

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1744
owl#annotatedSource
t345712
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0060781
core#notation
DOID:0060781
oboInOwl#hasDbXref
ORDO:103908
IAO_0000115
A secretory diarrhea that has_material_basis_in homozygous or compound heterozygous mutation in the SPINT2 gene on chromosome 19q13.
rdf-schema#label
congenital secretory sodium diarrhea 3
oboInOwl#hasExactSynonym
congenital secretory sodium diarrhoea 3 with or without other congenital anomalies
rdf-schema#subClassOf
t345861
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
RO_0002452
http://purl.obolibrary.org/obo/SYMP_0000570
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
RO_0004019
http://purl.obolibrary.org/obo/HP_0001197
relatedICD
http://example.org/icd10/P78.3
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.